A new study published today in Science Translational Medicine from the team of Shawn Hingtgen, Ryan Miller, and Matt Ewend at the UNC Eshelman School of Pharmacy and School of Medicine shows that human skin cells converted to neural stem cells deliver therapeutics that inhibit progression of the deadliest adult brain tumor, glioblastoma.
Read more about this important discovery in UNC Spotlights, Lineberger Pathways, at the UNC School of Pharmacy, and at Science Translational Medicine.